Investors



EXCHANGE: NASDAQ
Change
Change (%)
Volume
Data as of
Minimum 15 minute delay
Refresh quote

LEARN MORE

Recent Press Releases

  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (NASDAQ: APEN), a medical technology company primarily focused on the design, development and commercialization of innovative medical devices that can be used for the treatment of obesity, today announced the pricing of an underwritten public offering of 5,689,090 shares of its common stock at a public offering price of $5.50 per share, before underwriting discounts and commissions. All of the common stock is beingmore...
  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo") (NASDAQ: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced certain preliminary unaudited financial expectations for the three months ended June 30, 2017, including preliminary revenue and operating loss estimates and expected cash balance. Preliminary Unaudited Second Quarter 2017 Financial Expectations Total GAAP revenuemore...
Business Wire InvestorHQ℠